Showing results (71-80 of 108) with videos related to
Sort By:
Pageof 11
The Journal of Pathology|December 23, 2024
Tumour purity assessment with deep learning in colorectal cancer and impact on molecular analysisLydia A Schoenpflug, Aikaterini Chatzipli, Korsuk Sirinukunwattana, et al.Clinical Pharmacology and Therapeutics|August 24, 2025
Association Between Daily Timing of Everolimus and Survival in High-Risk HR+/HER2- Early Breast Cancer: A Sub-Analysis of the UCBG-UNIRAD TrialEnora Laas, Anne-Sophie Hamy, Thomas Bachelot, et al.Gut|July 22, 2020
Image-based consensus molecular subtype (imCMS) classification of colorectal cancer using deep learningKorsuk Sirinukunwattana, Enric Domingo, Susan D Richman, et al.Nature Communications|January 6, 2026
Neoadjuvant immune checkpoint blockade before chemoradiation for cervical squamous carcinoma (GINECO window-of-opportunity COLIBRI study): a phase II trialIsabelle Ray-Coquard, Marie-Christine Kaminsky-Forrett, Ryotaro Ohkuma, et al.European Journal of Cancer (Oxford, England : 1990)|October 31, 2020
Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study (GCO-002 CACOVID-19)Astrid Lièvre, Anthony Turpin, Isabelle Ray-Coquard, et al.Gynecologic Oncology|October 26, 2021
Regorafenib or Tamoxifen for platinum-sensitive recurrent ovarian cancer with rising CA125 and no evidence of clinical or RECIST progression: A GINECO randomized phase II trial (REGOVAR)Olivier Trédan, Magali Provansal, Cyril Abdeddaim, et al.JAMA Oncology|February 1, 2019
Effect of Adding Docetaxel to Androgen-Deprivation Therapy in Patients With High-Risk Prostate Cancer With Rising Prostate-Specific Antigen Levels After Primary Local Therapy: A Randomized Clinical TrialStéphane Oudard, Igor Latorzeff, Armelle Caty, et al.Nature Genetics|April 29, 2008
Identification of somatically acquired rearrangements in cancer using genome-wide massively parallel paired-end sequencingPeter J Campbell, Philip J Stephens, Erin D Pleasance, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 23, 2022
Everolimus Added to Adjuvant Endocrine Therapy in Patients With High-Risk Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Primary Breast CancerThomas Bachelot, Paul Cottu, Sylvie Chabaud, et al.Maturitas|February 4, 2022
The essential menopause curriculum for healthcare professionals: A European Menopause and Andropause Society (EMAS) position statementMargaret Rees, Kathy Abernethy, Gloria Bachmann, et al.Pageof 11